Does insulin resistance cause restless legs syndrome (RLS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Insulin Resistance Cause RLS?

Insulin resistance does not directly cause RLS, but there is a significant association between the two conditions, with insulin resistance and glucose metabolism abnormalities appearing substantially more common in patients with idiopathic RLS than in the general population.

The Evidence for Association

The relationship between insulin resistance and RLS is correlative rather than clearly causal:

  • Impaired glucose tolerance (IGT) is markedly elevated in idiopathic RLS patients. A 2009 study found that 41% of RLS patients had IGT compared to only 18% of controls, and 19% had newly diagnosed diabetes versus 6% of controls (p=0.002) 1. This suggests glucose metabolism dysfunction is frequently present even when fasting glucose appears normal.

  • The triglyceride-glucose (TyG) index, a marker of insulin resistance, correlates with RLS severity. A 2024 study demonstrated that the TyG index was significantly higher in RLS patients and showed positive correlation with disease duration and severity 2. This provides more direct evidence linking insulin resistance markers to RLS pathology.

  • Diabetes substantially increases RLS risk. A 2022 pooled analysis of 835,986 participants found that 25% of people with diabetes have RLS, and diabetics have nearly double the risk of developing RLS compared to non-diabetics (OR 1.98,95% CI 1.66-2.34) 3.

The Mechanism Remains Unclear

The directionality and mechanism of this relationship is uncertain:

  • Insulin resistance could contribute to RLS through metabolic or neurological pathways
  • Chronic sleep disruption from RLS could promote insulin resistance development 4
  • Diabetic peripheral neuropathy may mimic or coexist with RLS, complicating diagnosis 5
  • Shared underlying pathophysiology may link both conditions

Importantly, insulin resistance itself was not significantly different between RLS patients and controls in at least one study using HOMA-Index 1, suggesting the relationship may be more complex than simple insulin resistance causing RLS.

Clinical Implications

Screen all idiopathic RLS patients for glucose metabolism abnormalities, even with normal fasting glucose. Consider a 2-hour oral glucose tolerance test (OGTT) in RLS patients to identify prediabetes or undiagnosed diabetes 1.

The most recent 2025 AASM guidelines for RLS treatment 6 do not specifically address insulin resistance as a causative factor or treatment target, focusing instead on iron status, alpha-2-delta ligands (gabapentin, pregabalin), and other symptomatic treatments. This guideline omission further suggests insulin resistance is an associated condition rather than a primary cause requiring specific intervention.

When RLS coexists with diabetic neuropathy, prioritize glucose control first, then treat RLS symptoms with alpha-2-delta ligands like gabapentin or pregabalin 5, which address both neuropathic pain and RLS symptoms.

Related Questions

How should I further evaluate and manage a 42-year-old female with a four-year history of bilateral restless‑leg symptoms that improve with movement, who has hypothyroidism treated with levothyroxine 100 µg daily, has been taking omeprazole 20 mg each morning for two years, and medroxyprogesterone 10 mg daily for four months for polycystic ovary syndrome, with stable oxygen saturation, pulse, blood pressure, weight 70 kg, height 150 cm (BMI ≈31)?
How should I approach a 57-year-old female presenting with a one-day fever, recent bereavement-related insomnia, known restless‑leg syndrome treated with pregabalin 150 mg, and unexplained thrombocytopenia, with vitals SpO₂ 98%, pulse 84 bpm, temperature 37.5 °C, blood pressure 110/70 mmHg?
In a 64-year-old man with diabetes and restless legs syndrome who has nighttime leg pain despite gabapentin 100 mg at bedtime and normal iron and ferritin levels, what is the next best step in management?
What antipsychotic alternative to aripiprazole (Abilify) is suitable for a female patient with restless‑leg syndrome and intermittent, partially voluntary shaking she attributes to the medication?
In a 65-year-old woman with hypertension, type 2 diabetes mellitus, atrial fibrillation on lisinopril, metformin, and atorvastatin, and a normal CBC, who has worsening restless‑legs symptoms at night, which laboratory test should be obtained first: serum ferritin (with iron studies), vitamin B12, thyroid‑stimulating hormone (TSH), or vitamin D level?
Can you provide the article that demonstrates nicotine from cigarette smoke can kill an embedded tick?
Is there any scientific evidence that smoking cigarettes prevents tick bites?
Which antipsychotic medications are safe to use in a patient receiving amiodarone, considering QT interval prolongation and CYP3A4 drug interactions?
What is the appropriate treatment for mild pulmonary emphysema detected on computed tomography (CT) scan?
What are the normal reference ranges for a DHEA‑Sulfate (DHEA‑S) serum test and how should high or low results be interpreted?
What are the risks of long-term benzonatate (100 mg) therapy for a persistent dry cough in a patient with a normal chest X‑ray?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.